5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer Robinson D, Garmo H, Holmberg L, Stattin P Cancer Causes Control. 2015 Jun 25. [Epub ahead of print] PMID: 26109464 Background I show this […]
Aromatase inhibitors in male breast cancer: a pooled analysis Zagouri F, Sergentanis TN, Azim HA Jr, Chrysikos D, Dimopoulos MA, Psaltopoulou T Breast Cancer Res Treat. 2015 May;151(1):141-7. doi: 10.1007/s10549-015-3356-9. Epub 2015 Apr 8. Background […]
Today is day 1,000 since I was diagnosed back in September 2012, and so is as good a day as any for taking stock. Health I am doing fine. I am living the Tamoxifen life […]
Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, […]
A novel PALB2 truncating mutation in an Italian family with male breast cancer Vietri MT, Caliendo G, Casamassimi A, Cioffi M, De Paola ML, Napoli C, Molinari AM Oncol Rep. 2015 Mar;33(3):1243-7. doi: 10.3892/or.2014.3685. Epub […]
Identification of a new BRCA2 large genomic deletion associated with high risk male breast cancer Timoteo AR, Albuquerque BM, Moura PC, Ramos CC, Agnez-Lima LF, Walsh T, King MC, Lajus TB Hered Cancer Clin Pract. […]
